The trademark application RELOPCO was filed by Bristol-Myers Squibb Company, a U.S. corporation (the "Applicant"). The application was published for oppositions on August 9, 2020, and it was registered by office on November 17, 2020 without any oppositions.
The application was filed in English (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on January 6, 2021. Appointment and Replacement of representative of the trademark registration was recorded on April 5, 2021. Change of name and professional address of the trademark registration was recorded on January 11, 2024.